Author

Othon Wiltz

Montefiore Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Chaoyuan KuangiD· 1 shared Christiana MoiD· 1 shared Doctor Yitzchak GoldsteiniD· 1 shared Edward ChuiD· 1 shared Juan DuiD· 1 shared Kohtaro OokaiD· 1 shared Mahshid MohammadiiD· 1 shared Melanie Quintal· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chaoyuan KuangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cyclin-dependent kinase 9 inhibitors as oncogene signaling modulators in combination with targeted therapy for the treatment of colorectal cancer

Mahshid Mohammadi, Muzaffer Ahmed Bhat, T. Li, Ning Wei, Priyanka Patil, Christiana Mo, Natalie Thielen, Zimo Huang, Juan Du, Doctor Yitzchak Goldstein, Othon Wiltz, Renee Huang, Kohtaro Ooka, Melanie Quintal, Edward Chu, Chaoyuan Kuang

This study evaluates CDK9 inhibitors in CRC models, showing potent anti-proliferative effects and synergy with MEK inhibitors, suggesting a potential combination therapy for CRC.

bioRxiv · Aug 13, 2025 · PreprintCancer Biology